Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder.

Autor: Balog, Brian M.1,2,3, Tangada, Abhilasha1,2, Sheth, Pooja1, Song, Qi-Xiang1,2,4, Couri, Bruna M.1,5, Porras, Leah L.6, Deng, Gary G.6, Damaser, Margot S.1,2,7 damasem@ccf.org
Zdroj: PLoS ONE. 8/28/2019, Vol. 14 Issue 8, p1-15. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje